Search results :

Cefepime

More information: STITCH, PubChem (stereo-specific compound: 1) and possibly Wikipedia

ATC Code: J01DE01

Side effects

Options: Show MedDRA Preferred Terms

Side effect Data for drug Placebo Labels
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15
Haemolysis 18.7% x x
Infection 1% - 10% x
Pneumonia 1% - 10% x
Septicemia 2% - 10% x
Abdominal infection 2% - 10% x
Bronchitis 1% - 10% x
Diarrhoea 1.2% - 3% x x x x x x x x x x x x x x x
Local reaction 3% x x x x x x x x x x x x x x x
Phosphorus low 2.8% x x x x x x x x x x x
Nausea 2% x x x x x x x x x x x x x x x
Rash 1.1% - 4% x x x x x x x x x x x x x x x
Phlebitis 1.3% - 2.9% x x x x x x x x x x x x x x x
Body temperature increased 1% - 7% x x x x x x x x x x x x x
Headache 1% x x x x x x x x x x x x x x x
Pruritus 1% x x x x x x x x x x x x x x x
Vomiting 1% x x x x x x x x x x x x x x x
Inflammation 0.1% - 0.6% x x x x x x x x x x x x x x x
Agranulocytosis postmarketing x x x x x x x x x x x x x x x
Anaphylactic shock postmarketing x x x x x x x x x x x x x x x
Anaemia postmarketing x x x x x x x
Aplastic anaemia postmarketing x x x x x x x x x x x x x x x
Haemolytic anaemia postmarketing x x x x x x x x x x x x x x
Cholestasis postmarketing x x x x x x x x x x x x x x x
Coma postmarketing x x x x x x x x x x x x x x x
Confusional state postmarketing x x x x x x x x x x x x x x
Toxic epidermal necrolysis postmarketing x x x x x x x x x x x x x x x
Erythema multiforme postmarketing x x x x x x x x x x x x x x x
Hallucination postmarketing x x x x x x x x x x x x x x x
Haemorrhage postmarketing x x x x x x x x x x x x x x x
Leukopenia postmarketing x x x x x x x x x x x x x x x
Myoclonus postmarketing x x x x x x x x x x x x x x x
Neutropenia postmarketing x x x x x x x x x x x x
Pancytopenia postmarketing x x x x x x x x x x x x x
Renal failure postmarketing x x x x x x x x x x
Convulsion postmarketing x x x x x x x x x x x x x x x
Stevens-Johnson syndrome postmarketing x x x x x x x x x x x x x x x
Thrombocytopenia postmarketing x x x x x x x x x x x x x x x
Urticaria postmarketing x x x x x x x x x x x x x x x
Encephalopathy postmarketing x x x x x x x x x x x x x x x
Stupor postmarketing x x x x x x x x x x x x x x x
Hepatic function abnormal postmarketing x x x x x x
Consciousness abnormal postmarketing x x x x x x x x x x x x x x
Neurotoxicity postmarketing x x x x x x
Nephropathy toxic postmarketing x x x x x x x x x x x x x x x
Nonconvulsive status epilepticus postmarketing x x x x x x
Hepatic impairment postmarketing x x
Renal impairment postmarketing x x x x x x x x x x x
Abdominal pain x x x
Candida infection x x x
Oral candidiasis x x x x x x x x x x x x x x x
Vaginal moniliasis x
Colitis x x x x x x x x x x x x x x x
Constipation x x x
Dizziness x x x
Dysgeusia x x x
Dyspnoea x x x
Eosinophilia x x x
Extravasation x
Hypersensitivity x x x x x
Hypocalcaemia x x x
Pain x x x x x x x x x x x x x x x
Paraesthesia x x x
Pruritus genital x
Pyelonephritis x
Shock x
Erythema x x x x x x x
Urinary tract infection x
Vaginal inflammation x x x x x x x x x x x x x x x
Vasodilation x x x
Chills x x x
Hepatic failure x
Injection site inflammation x x x
Phosphatase alkaline increased x x x x x x x x x x x x
Prothrombin level increased x x x
Alanine aminotransferase increased x x x x x x x x x x x x
Fatal outcomes x
Disability x x x x x x x x x x x
Excitability x
Muscle mass x
Pneumonia due to Streptococcus, group b x
Gastrointestinal symptom NOS x x x
Ca++ increased x
Potassium increased x
Calcium low x x x x x x x x x x x x x
Pseudomembranous colitis x x x x x x x x x x x x x x x

Indications

Information about indications was extracted from the indications and usage sections of the labels.

CEFEPIME

Side effects:44
Source:FDA Structured Product Label

CEFEPIME HYDROCHLORIDE / MAXIPIME

Side effects:44
Source:FDA

CEFEPIME HYDROCHLORIDE / MAXIPIME

Side effects:45
Source:FDA

Cefepime Hydrochloride / Maxipime

Side effects:45
Source:FDA

CEFEPIME

Side effects:46
Source:FDA Structured Product Label

CEFEPIME

Side effects:46
Source:FDA Structured Product Label

CEFEPIME

Side effects:47
Source:FDA Structured Product Label

CEFEPIME

Side effects:46
Source:FDA Structured Product Label

CEFEPIME

Side effects:47
Source:FDA Structured Product Label

CEFEPIME

Side effects:47
Source:FDA Structured Product Label

CEFEPIME

Side effects:49
Source:FDA Structured Product Label

CEFEPIME

Side effects:50
Source:FDA Structured Product Label

Cefepime hydrochloride / APPROVED NAME:

Side effects:53
Source:medicines.org.au

Color scheme:

standard – alternative

    100%
    75%
    50%
    10%
    frequent (1% to 100%)
    infrequent (0.1% to 1%)
    rare (<0.1%)
    postmarketing
    0%
    no frequency information
    not found on label